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Bone marrow endothelial cells (ECs) are essential
for reconstitution of hematopoiesis, but their role in
self-renewal of long-term hematopoietic stem cells
(LT-HSCs) is unknown. We have developed angio-
genic models to demonstrate that EC-derived angio-
crine growth factors support in vitro self-renewal and
in vivo repopulation of authentic LT-HSCs. In serum/
cytokine-free cocultures, ECs, through direct cellular
contact, stimulated incremental expansion of repo-
pulating CD34Flt3cKit+LineageSca1+ LT-HSCs,
which retained their self-renewal ability, as deter-
mined by single-cell and serial transplantation
assays. Angiocrine expression of Notch ligands by
ECs promoted proliferation and prevented exhaus-
tion of LT-HSCs derived from wild-type, but not
Notch1/Notch2-deficient, mice. In transgenic notch-
reporter (TNR.Gfp) mice, regenerating TNR.Gfp+
LT-HSCs were detected in cellular contact with sinu-
soidal ECs. Interference with angiocrine, but not
perfusion, function of SECs impaired repopulation
of TNR.Gfp+ LT-HSCs. ECs establish an instructive
vascular niche for clinical-scale expansion of
LT-HSCs and a cellular platform to identify stem cell-
active trophogens.
INTRODUCTION
Maintenance of long-term hematopoietic stem cells (LT-HSCs)
at steady-state conditions and reconstitution after myeloablation
are two distinct physiological processes that are dependent on
extrinsic signals conveyed by the bone marrow (BM) niches
(Till et al., 1964). Initial studies attempting to study the interactionof HSCs with their niches were centered on identifying soluble
factors released by the BM stromal cells that support the expan-
sion of LT-HSCs. With serum-free cultures, it was demonstrated
that a combination of soluble kit-ligand (sKitL), thrombopoietin,
Flk-2, and angiopoietin-like factors could augment HSC expan-
sion, with one study demonstrating a 24-fold expansion of
LT-HSCs (Krosl et al., 2003; Miller and Eaves, 1997; Willert
et al., 2003; Zhang et al., 2006). Others have shown that the intro-
duction of HoxB4 and Notch-1 increases HSC numbers, as well
(Antonchuk et al., 2002; Varnum-Finney et al., 2000). However, in
these stroma-free cultures, there is a rapid attrition of HSCs, sug-
gesting that the interaction of the HSCs with BM stromal or
vascular cells may be necessary to support long-term self-
renewal and maintenance of HSCs.
Among the known BM stromal cells, osteoblasts/osteoclasts,
‘‘the osteogenic niche,’’ is believed to mediate the quiescent
state and size of the phenotypically marked putative HSCs
(Arai et al., 2004; Calvi et al., 2003; Heissig et al., 2002; Kollet
et al., 2006; Zhang et al., 2003). Similarly, phenotypically marked
HSCs, including CD150+CD48CD41KLS cells, localize to the
BM endothelial cells (ECs), ‘‘the vascular niche’’ (Avecilla et al.,
2004; Kiel et al., 2005; Kopp et al., 2006; Rafii et al., 1995), raising
the possibility that ECs might modulate HSC homeostasis. We
have shown that BM sinusoidal ECs (SECs), demarcated by
the VEGFR3+Sca1VE-cadherin+VEGFR2+ SECs, constitute the
predominant surface area of the BM vascular niche (BMVN)
(Hooper et al., 2009) and are essential for engraftment and
reconstitution of hematopoiesis. However, in the Hooper et al.
(2009) study, the role of ECs in replenishing bona fide LT-HSCs
was not evaluated. Thus, it remains to be determined whether
ECs are essential for the self-renewal of LT-HSCs in vitro or
BM repopulation in vivo. Furthermore, the mechanism by which
ECs might support long-term expansion and differentiation of
LT-HSCs remains unknown.
To define the role of ECs in LT-HSC self-renewal and mainte-
nance, we have devised a model in which ECs are cocultured
with hematopoietic cells for weeks in serum- and cytokine-freeCell Stem Cell 6, 251–264, March 5, 2010 ª2010 Elsevier Inc. 251
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promoting cellular attrition (Ramalingam et al., 1999; Seandel
et al., 2008; Zhang et al., 2004, 2005). Herein, we demonstrate
that coculture of putative mouse HSCs in direct cellular contact
with ECs in serum-free cultures, supplemented only with soluble
Kit ligand (sKitL), is required for incremental self-renewal of
LT-HSCs beyond 21 days, with one of every four cells represent-
ing an authentic repopulating LT-HSC. ECs support self-renewal
of LT-HSCs through elaboration of EC-derived stem cell active
growth factors and trophogens, referred to as angiocrine factors
(Butler et al., 2010). By using the transgenic notch reporter
(TNR.Gfp) mice, in which stimulation of the Notch signaling
pathway results in GFP expression, we demonstrate that ECs
support long-term expansion of TNR.Gfp+cKit+Sca-1+Lineage
(TNR.Gfp+KLS), but not Notch1/Notch2/ CD34Flt-3KLS
LT-HSCs. Blocking the angiocrine function of the SECs without
interfering with the perfusion capacity of the SECs results in
impaired replenishment of TNR.Gfp+KLS cells. These results
suggest that the vascular niche, which is an essential com-
ponent of the BM microenvironment, balances the expansion
and differentiation of LT-HSCs through expression of angiocrine
factors that prevent the exhaustion of the repopulating LT-HSC
pool.
RESULTS
E4ORF1+ ECs Expand and Maintain LT-HSCs
in Serum- and Cytokine-Free Conditions
The use of ECs to support long-term self-renewal of HSCs has
been hindered by a lack of serum- and cytokine-free coculture
models in which ECs maintaining their angiogenic potential
could be cultivated in vitro or selectively targeted in vivo.
Depriving EC cultures of serum or essential EC growth factors
results in apoptosis, thereby making it impractical to study the
role of ECs in sustaining long-term HSC self-renewal. Further-
more, the requirement for supplementation of EC cultures with
exogenous recombinant growth factors, such as FGF-2 and
IGF, may mask the true potential of ECs in promoting LT-HSC
expansion, because these growth factors could directly influ-
ence the expansion of stem cells. To circumvent these hurdles,
we have developed a reproducible culture system in which intro-
duction of the adenoviral E4ORF1 gene into human primary ECs
(E4ORF1+ ECs) allows for long-term cultures of ECs in serum-
and cytokine-free conditions without compromising their prolif-
erative and angiogenic properties (Seandel et al., 2008; Zhang
et al., 2004, 2005). To elaborate on the unique capability of
E4ORF1+ ECs to survive under serum- and cytokine-free culture
conditions and the potential to support HSCs, we compared
E4ORF1+ ECs to other EC lines, including freshly isolated ECs
(HUVECs), immortalized SV40 large T BM ECs (BMECs), and
hTERT BMECs (Figure S1A available online). Only E4ORF1+
ECs maintained their integrity in serum- and cytokine-free
cultures, whereas other primary and immortalized EC cell lines
underwent apoptosis (Figures S1A and S1B). Therefore,
E4ORF1+ ECs provide an ideal cellular platform to interrogate
the role of ECs in regulating LT-HSC homeostasis.
To study the role of ECs in expanding and maintaining
LT-HSCs, lineage-negative (Lin) mouse BM-derived hemato-
poietic stem and progenitor cells (HSPCs) were cocultured252 Cell Stem Cell 6, 251–264, March 5, 2010 ª2010 Elsevier Inc.with E4ORF1+ ECs in serum- and cytokine-free conditions, sup-
plemented only with mouse sKitL (Figures S2A and S2B).
Cultures were fed by replacing the serum- and cytokine-free
media with sKitL every other day. Hematopoietic cells were
then analyzed every 7 days by separating the Lin from
lineage-positive (Lin+) cells and ECs (Figures S2A and S2B).
There was an increase in total number of Lin and Lin+ hemato-
poietic cells over time (Figures S2C and S2D). Within the Lin
population, there was a substantial increase in phenotypically
marked KLS and Lin+ mature CD11b+Gr1+ myeloid and
CD41a+ megakaryocytic precursor cells (Figures S2C and
S2E), suggesting that E4ORF1+ ECs could support expansion
of immature HSPCs as well as differentiation of these cells into
mature precursor cells.
Because generation of large numbers of Lin+ cells deplete the
nutrients thereby compromising the true potential of E4ORF1+
ECs to self-renew LT-HSCs, we developed a model to remove
the expanding Lin+ mature cells during the coculture period. To
this end, 1000 KLS cells freshly isolated from the BM of the
wild-type (WT) CD45.2+ mice were cocultured with either
E4ORF1+ ECs + sKitL or sKitL alone. Subsequently, every
week the expanding Sca-1+Lineage cells were separated from
proliferating mature Lin+ cells and replated on E4ORF1+ ECs
(Figure 1A). Coculture of KLS cells with E4ORF1+ ECs and sKitL
resulted in a dramatic hematopoietic cell expansion for more
than 21 days without attrition of the EC monolayers (Figures
1B and 1C). Within the expanded hematopoietic cell population,
we found an increase in progenitor cell numbers as determined
by a colony-forming cell assay (CFU, Figure 1D) and a significant
expansion of phenotypically marked KLS cells by 4 weeks of
coculture (Figure 1E; Figure S3). Notably, KLS cells cultured in
serum-free media and sKitL alone were unable to survive by
4 weeks (Figure 1C).
The increase in phenotypically marked KLS cells in EC cocul-
tures does not accurately reflect the number of repopulating
LT-HSCs. Therefore, we examined the long-term repopulation
capacity of expanded KLS cells in BM transplantation assays.
First, we examined the stem cell potential of cocultured KLS cells
by performing a two-dose competitive repopulation assay,
which revealed that as few as 1000 KLS cells cocultured with
E4ORF1+ ECs + sKitL for 3 weeks supported long-term (>12
months) multilineage engraftment in all transplanted mice
(Figures 2A, 2B, and 2D). By contrast, KLS cells cultured with
sKitL alone for 3 weeks supported only short-term engraftment
(<2 months) (Figure 2A).
To test the self-renewal potential of the LT-HSCs cocultured
with E4ORF1+ ECs, we performed serial transplantation assays.
Whole BMmononuclear cells were isolated from long-term, mul-
tilineage engrafted mice (Figure 2A), and CD45.2+ hematopoietic
cells (progeny of cells cocultured with ECs) were sorted and
transplanted into lethally irradiated secondary recipients. By
transplanting only CD45.2+ cells, it allowed us to demonstrate
that the hematopoietic cells that were cocultured with ECs
were able to sustain long-term, multilineage engraftment in all
secondary recipients (Figure 2D).
To accurately quantify the frequency of true LT-HSCs expand-
ing in cellular contact with E4ORF1+ ECs,we performed a limiting
dilution assay in which day 21 cocultured proliferating hemato-
poietic cells were injected at different doses of 1, 5, 10, and
Figure 1. Serum- and Cytokine-Free E4ORF1+ EC Cocultures Expand Phenotypically Marked HSCs
(A) Schematic representing assay for serial ex vivo expansion of hematopoietic cells.
(B) Representative phase-contrast micrographs of proliferating hematopoietic cells cocultured with E4ORF1+ EC + sKitL at day 0 and day 28.
(C) Comparison of total lineage-negative hematopoietic cell expansion from culture systems that included the conditions E4ORF1+ EC + sKitL or sKitL alone.
(D) 5000 enriched Sca1+Lineage cells from both culture conditions and were mixed with methylcellulose containing cytokines to generate total colony forming
units (CFU).
(E) Total lineage-negative hematopoietic cells were compared from culture conditions that included E4ORF1+ EC + sKitL or sKitL alone for HSC phenotypic
expression of KLS.
Error bars represent SD based on three to four independent experiments (*p < 0.05, n = 10).
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ient mice along with a competitive dose of recipient BM. The
frequency of long-term reconstituting cells (CRU) was calculated
according to Poisson statistics and was found to be one out of
every four cells (Figure 2C). Thus, E4ORF1+ ECs provide a unique
vascular platform that not only maintains, but also stimulates,
long-term expansion of true repopulating LT-HSCs under
a serum- and cytokine-free microenvironment.
LT-HSCs Derived from EC Cocultures Do Not Exhibit
Signs of Leukemia
One concern of being able to expand such a proliferative popu-
lation of LT-HSCs is that KLS cells cocultured with E4ORF1+ ECs
may have acquired aberrant properties of leukemic cells.However, all of the mice transplanted with cocultured LT-HSCs
and those that had undergone secondary or single-cell trans-
plantation survived beyond 1 year and the circulating blood
counts of primary, secondary, and single-cell transplanted
mice were comparable to nontransplanted control mice, mani-
festing normal white blood cell, hematocrit, and platelet counts
(Figure S4). These data suggest that cocultured KLS cells have
not undergone any leukemogenic transformation and ECs
through secretion of stem cell active angiocrine factors sustain
self-renewal of KLS cells.
ECs Activate Notch Signaling on Cocultured KLS Cells
Endothelial cells have been speculated to modulate the homeo-
stasis of normal and malignant organ-specific stem cellsCell Stem Cell 6, 251–264, March 5, 2010 ª2010 Elsevier Inc. 253
Figure 2. Hematopoietic Cells Cocultured
with E4ORF1+ ECs and sKitL Give Rise to
Long-Term Multilineage Engraftment and
Maintain Self-Renewal Capacity
(A) Comparison of engraftment efficiency between
10,000 freshly isolated Sca1+Lineage (control)
(n = 10) versus hematopoietic cells cocultured for
3 weeks with E4ORF1+ ECs + sKitL (n = 10) versus
hematopoietic cells cultured for 3weekswith sKitL
alone (n = 10), with a two-dose competitive repo-
pulation assay. As few as 1,000 and 10,000 hema-
topoietic cells cocultured with E4ORF1+ ECs +
sKitL gave rise to long-term multilineage engraft-
ment and out-competed the standard competitive
dose of 200,000 freshly isolated CD45.1
whole BM.
(B) The percentage of long-term multilineage
engraftment in both test cell numbers in the hema-
topoietic cells cocultured with E4ORF1+ ECs and
sKitL.
(C) Limiting dilution assay to determine the
frequency of LT-HSCs in day 21 cocultured hema-
topoietic cells. CRU of 1 in 4 was determined with
Poisson statistics by L-calc software (Stem Cell
Technologies).
(D) Whole BM was isolated from mice that
had been long-term engrafted (A) and CD45.2
cells were sorted and were transplanted into le-
thaly irradiated (950 Rads) secondary recipients
(n = 10), as depicted in schematic. The primary
cells that were cocultured with E4ORF1+ ECs
and sKitL were able to sustain self-renewal, as is
shown in the representative FACS dot plot
showing long-term multilineage engraftment in all
secondary recipients.
Error bars represent SD.
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Notch ligands (Butler et al., 2010). In agreement with published
reports (Fernandez et al., 2008; Karanu et al., 2000), we show
by qPCR (Figure S5A) and protein expression (Figure S5C)
that ECs express Jagged-1, Jagged-2, and Dll4 and Dll1 (data
not shown), suggesting that activation of Notch may contribute
to expansion of the cocultured HSCs. Notch-1 is expressed on
LT-HSCs and maintains HSCs in an undifferentiated state (Calvi
et al., 2003; Duncan et al., 2005; Wu et al., 2007). Overexpres-
sion of the intracellular domain of Notch enhances HSC self-
renewal (Varnum-Finney et al., 2000), whereas loss of Notch
signaling impairs the maintenance of HSCs both in vitro and
in vivo (Calvi et al., 2003; Hadland et al., 2004). However, at
steady-state conditions, maintenance of the HSCs has been254 Cell Stem Cell 6, 251–264, March 5, 2010 ª2010 Elsevier Inc.shown to be independent of Notch
signaling (Maillard et al., 2008; Mancini
et al., 2005), but its role in reconstitution
of HSCs after myeloablation remains
unknown. Indeed, the role of Notch
signaling after severe irradiation-induced
hemangiogenic regression or repetitive
myelosuppressive insults as is instituted
in patients undergoing chronic che-
motherapy is unknown. Therefore, we
hypothesized that angiocrine expressionof Notch ligands by ECs promote self-renewal of HSCs through
reducing the exhaustive differentiation into lineage-committed
progenitors.
To test this hypothesis, we used a transgenic mouse that
expresses the GFP reporter gene in cells that are actively
signaling through Notch (transgenic Notch reporter mouse,
TNR.Gfp) (Duncan et al., 2005; Mizutani et al., 2007). We found
that hematopoietic cells derived from the BM of TNR.Gfp mice
(TNR.Gfp hematopoietic cells) cocultured with E4ORF1+ ECs
increase Gfp expression over time (Figure 3A), suggesting that
ECs stimulate Notch signaling on hematopoietic cells. Further-
more, the majority of the hematopoietic cells isolated
from TNR.Gfp mice that form colonies in coculture with ECs
were activated through Notch pathway expressing Gfp
Figure 3. Notch Signaling Is Activated in Hematopoietic Cells Cocultured with E4ORF1+ ECs and sKitL
(A) 1000 freshly isolated KLS hematopoietic cells from the BM of TNR.Gfpmice were cocultured with E4ORF1+ ECs and sKitL. The degree of Notch signaling in
the culture increased over time as indicated by enhanced Gfp expression (TNR.Gfp+ cells) in the expanding hematopoietic cells.
(B) Hematopoietic colonies that attach to ECs increase Notch signaling over time.
(C) Quantification of total number of TNR.Gfp+ Lin versus Lin+ hematopoietic cell expansion. TNR.Gfp+ hematopoietic cells cultured in the absence of endo-
thelium died by 3 weeks in culture.
(D) Phenotypic expression comparing the expansion of total KLS versus TNR.Gfp+ KLS cells expanded in the presence of E4ORF1+ ECs and sKitL.
(E and F) TNR.Gfp hematopoietic cells cultured in direct cellular contact with E4ORF1+ EC + sKitL or placed on the upper chamber of the transwells, physically
separated from E4ORF1+ ECs. Lack of cellular contact of the TNR.Gfp hematopoietic cells with the E4ORF1+ EC monolayers, even in the presence of sKitL,
results in a severe impairment of survival and diminished proliferation of the Lin TNR.Gfp hematopoietic cells (E) and impaired expansion of TNR.Gfp+ KLS cells
(F). By contrast, TNR.Gfp hematopoietic cells that were cultured in direct cellular contact with E4ORF1+ ECs and sKitL underwent significant expansion over
a 28 day period, generating large numbers of Lin TNR.Gfp (E) and TNR.Gfp+ KLS cells (F).
Error bars represent SD (*p < 0.05, n = 6).
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Endothelial Cells Support Stem Cell Self-Renewal(TNR.Gfp+ hematopoietic cells) (Figure 3B). Phenotypic analysis
of the TNR.Gfp cells cocultured with ECs for 4 weeks showed
that 90% of the expanding cells were composed of Lin hema-
topoietic cells (Figures 3C and 3D), of which 60% comprised of
TNR.Gfp+ HSPCs (Figure 3D). Thus, Notch expression supports
proliferation of immature hematopoietic cells in EC cocultures by
inhibiting excessive differentiation of HSPCs.Expansion of TNR.Gfp+ KLS Cells Requires Direct
Cellular Contact with ECs
During coculturing of TNR.Gfp KLS cells on E4ORF1+ ECs,
a large number of Notch-activated TNR.Gfp+ hematopoietic
cells forming cobblestone HSPC colonies were expanding
attached to the ECs (Figure 3B), suggesting that hematopoietic
cells required direct cellular contact with ECs to undergoCell Stem Cell 6, 251–264, March 5, 2010 ª2010 Elsevier Inc. 255
Figure 4. Blocking Angiogenic Pathways in
E4ORF1+ ECs Decreases Notch Signaling
Favoring Hematopoietic Cell Differentiation
(A) Representative FACS histographs demon-
strating a rapid decrease in Notch activity as
reflected in a reduction in Gfp expression in
TNR.Gfp hematopoietic cell population, when
treated with the g-secretase inhibitor or the
vascular targeting antibodies.
(B) Representative FACS histograms showing
a rapid increase in hematopoietic lineage markers
when treated with the g-secretase inhibitor or the
vascular targeting antibodies.
(C) Quantification of (A) (n = 3 wells, 3 independent
experiments).
(D) Annexin V/propidium iodide staining to deter-
mine whether the treatment with the g-secretase
inhibitor or the vascular targeting antibodies
caused a decrease in Gfp expression because of
hematopoietic cell death. There was no change
in cell viability after treatment.
(E) Quantification of (B) (n = 3, 3 independent
experiments).
(F) Quantification of percent engraftment of
200,000 CD45.2+ test cells cocultured with
E4ORF1+ ECs and sKitL with or without treatment
with the g-secretase inhibitor or the vascular
targeting antibodies against 200,000 standard
competitive dose of CD45.1+ freshly isolated
whole BM.
*p < 0.05, n = 10 mice per treatment group.
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KLS cells were either cocultured in direct cellular contact or
physically separated from the E4ORF1+ EC monolayers by
plating them on the upper chamber of 0.4 micron porous trans-
well plates. TNR.Gfp hematopoietic cells that were placed on the
transwells were unable to expand (Figures 3E and 3F), whereas
the cells plated in direct cellular contact with E4ORF1+ ECs
underwent significant expansion generating abundant colonies
of both TNR.Gfp Lin and TNR.Gfp+KLS cells (Figures 3E and
3F). These data suggest that direct cellular interaction between
ECs and HSPCs is essential for Notch activation supporting
the expansion of LT-HSCs.
Blocking Angiogenic Pathways Inhibits Notch Ligand
Expression and Decreases Expansion of LT-HSCs
To formally determine whether ECs support the proliferation of
LT-HSCs through Notch signaling, we disrupted signaling path-
ways that maintain EC angiogenic activity with neutralizing
monoclonal antibodies (mAbs) to vascular endothelial-cadherin
(VE-cadherin) and vascular endothelial growth factor receptor-2256 Cell Stem Cell 6, 251–264, March 5, 2010 ª2010 Elsevier Inc.(VEGFR2) that exert a synergistic effect
in maintaining EC survival through Akt
activation (Carmeliet et al., 1999). We
also evaluated the role of Notch activation
in expansion of LT-HSCs, by a g-secre-
tase inhibitor (Wolfe et al., 1999). Inhibi-
tion of the EC function with mAbs to
VE-cadherin and VEGFR2 or g-secretase
inhibitor for 3 days induced a markeddecrease in the expansion of TNR.Gfp+ hematopoietic cells in
culture (Figures 4A and 4C), favoring rapid differentiation of the
expanding cells (Figures 4B and 4E). There was no direct cyto-
toxicity caused by the mAbs on TNR.Gfp+ hematopoietic cells
(Figure 4D), suggesting that mAbs to angiogenic factors exert
their effect by targeting ECs. Moreover, g-secretase inhibitor
did not manifest any hematopoietic toxicity (Figure 4D). We
next determined whether either g-secretase inhibitor or abroga-
tion of EC angiogenic activity would result in a decrease in
engraftment efficiency of expanding cocultured hematopoietic
cells. We treated cocultures of CD45.2+ hematopoietic cells
with E4ORF1+ ECs for 3 weeks, with mAbs to VE-cadherin and
VEGFR2 or separately with the g-secretase inhibitor for 3 days.
We then transplanted 200,000 treated and untreated CD45.2+
hematopoietic cells cocultured with ECs along with 200,000
CD45.1+ whole BM into lethally irradiated CD45.1+ recipients.
Though all transplanted CD45.2+ (treated and untreated) cells
outcompeted the CD45.1+ hematopoietic cells, the populations
treated with mAbs to VE-cadherin and VEGFR2 or g-secretase
inhibitor engrafted poorly, suggesting that inhibition of
Cell Stem Cell
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signaling, decreases the frequency of LT-HSCs in coculture
with ECs (Figure 4F).
Angiocrine Expression of Notch Ligands by ECs
Reduces Exhaustion of TNR.Gfp+ KLS Cells
To determine whether angiogenic factors may regulate the
expression of Notch ligands on the ECs, we studied the expres-
sion patterns of Jagged-1 and Jagged-2 on the ECs. By using
immunohistochemistry to define the localization of Notch ligands
on ECs, we discovered that Jagged-2 expression was intracel-
lular and did not localize to the cell surface membrane (Fig-
ure S5C). Surveying an array of proangiogenic cytokines showed
that sKitL induces KLS cells to express and secrete VEGF-A164
(Figure S5B). Notably, when ECs were stimulated with VEGF-
A164, Jagged-2 translocated to the surface of the ECs.
Jagged-1 had no apparent change in protein localization after
VEGF-A164 stimulation (Figure S5C). Thus, sKitL, through the
induction of VEGF-A expression, facilitates recruitment of
Jagged-2 to the membrane of ECs, thereby supporting the
expansion of KLS cells.
If Notch activation is essential for expansion of LT-HSCs, then
expression of Notch receptors should bemaintained on expand-
ing immature hematopoietic cells. Via qPCR we found that both
Notch1 and Notch2were expressed on day 21 cocultured hema-
topoietic cells (Figure 5A). To determine the role of Notch
signaling in expansion of LT-HSC EC cocultures, we utilized
two experimental approaches to selectively block Notch activa-
tion on the expanding hematopoietic cells. The first approach
was to block Notch signaling on the hematopoietic cells in the
coculture with E4ORF1+ ECs by a high-affinity decoy construct
that comprises of the Notch1 receptor fused with IgG-Fc
domain, neutralizing all of the potential Notch ligands elaborated
by the ECs (Funahashi et al., 2008). Expansion of TNR.Gfp+
hematopoietic cells that were cocultured with E4ORF1+ ECs
transduced with an adenoviral vector expressing the Notch
decoy construct resulted in a profound decrease in proliferation
of TNR.Gfp+KLS and total hematopoietic cells. Conversely,
E4ORF1+ ECs transduced with a control adenoviral null vector
(AdNull) supported the expansion of TNR.Gfp+KLS and other
hematopoietic cells (Figure 5B).
In a second approach, we determined whether selective dele-
tion of Notch1 and Notch2 in undifferentiated LT-HSCs dimin-
ishes their expansion in cocultures with ECs. Lineage hemato-
poietic cells purified from the BM of Mx1-Cre-floxed Notch1/
Notch2 mice were treated with Poly I/C to generate Notch1/
Notch2/ mice. As control, Lin hematopoietic cells were also
obtained from the syngenic control WT mice. Equal numbers
of WT control and Notch1/Notch2/ Lin BM cells were co-
cultured on E4ORF1+ ECs with sKitL (Figure 5). Every 7 days,
WT and Notch1/Notch2/ hematopoietic cells were demide-
populated and Lin cells were replated on fresh E4ORF1+ ECs.
Analysis at day 21 demonstrated a significant decrease in
the total number of hematopoietic cells, and phenotypically
marked CD34Flt-3KLS HSCs within the expanding Notch1/
Notch2/ cocultured cells (Figures 5C–5G). Notably, when the
remaining Notch1/Notch2/ KLS cells on day 21 were trans-
planted into lethally irradiated mice the hematopoietic cells were
able to engraft and support long-term hematopoiesis (data notshown). These data suggest that Notch1,2 has no affect on the
functionality of the HSCs but promotes expansion of the
LT-HSCs by preventing the exhaustion of CD34Flt-3KLS
LT-HSCs in the E4ORF1+ EC coculture model. This finding
sets forth the notion that angiocrine expression of Notch ligands
by ECs promotes long-term expansion of LT-HSCs.
Vascular Targeting Blocks Angiocrine Expression
of Notch Ligands on Perfused SECs
Although the angiocrine function of the ECs could readily be as-
sessed in vitro, it is more cumbersome to determine whether
myeloablation afforded by irradiation primarily impairs the angio-
crine or the perfusion capacity of the SECs. Integrity of the SECs
during regeneration from irradiation injury is dependent on
proper signaling through EC-specific molecules VEGFR2 and
VE-cadherin. Activation of VEGFR2 is essential for reconstitution
of hematopoiesis after sublethal irradiation (Hooper et al., 2009).
However, in these studies the angiocrine role of the SECs and
vascular functionality of the SECs in mediating the regeneration
of repopulating LT-HSCs were not assessed. Thus, to determine
the distribution of Notch ligands on the functional perfused
SECs, the control and vascular targeted 650-irradiated mice
were intravenously injectedwith low doses of Alexa 647-VE-cad-
herin and Alexa 488-Isolectin 10 min before sacrificing the mice
to visualize the number of perfused type I vessels (Figure 6A;
Hooper et al., 2009). Subsequently, polyvariate flow cytometry
was used to quantify the number of functionally patent Isolec-
tin+VE-cadherin+Ter119CD45 SECs (Figures 6C and 6D;
Figure S6) that coexpress either Jagged-1 or Jagged-2 in control
and 650-irradiated mice after vascular targeting (Figures 6B and
6E). With this approach, we demonstrate that in untreated 650-
irradiated mice (Figure 6A, middle), and strikingly, even in mice
treated with both VEGFR2 and VE-cadherin mAbs (Figure 6A,
bottom), there was still a significant number of functional
perfused Isolectin+VE-cadherin+Ter119CD45 SECs present
throughout the femur (Figures 6A and 6C; Figure S6). Jagged-1
and Jagged-2 were coexpressed on SECs and their expression
levels were maintained on the functional SECs of the untreated
and irradiated mice (Figures 6B and 6E). By contrast, treatment
of the irradiated TNR.Gfp mice with mAbs to VEGFR2 and
VE-cadherin downregulated the expression of Jagged-1 and
Jagged-2 on the functional Isolectin+VE-cadherin+ SECs (Fig-
ures 6B and 6E).
In the 650-irradiated mice treated with vascular targeting
agents, the total number of individual ECs exposed to intrave-
nously injected Isolectin and VE-cadherin was decreased (Fig-
ure 6C). However, a significant number of type I (Hooper et al.,
2009) dilated but perfused Isolectin+VE-cadherin+ vessels were
still present in the BM of these mice (Figure 6A, bottom).
Although the vascular-targeted mice maintained a large number
of patent remodeling SECs, their instructive functions were
impaired because of downregulation of Jagged-1 and Jagged-
2 expression, suggesting that antiangiogenic agents impair the
angiocrine expression of Notch ligands of perfused SECs.
Blocking the Angiocrine Function of SECs Inhibits
Recovery of the Repopulating HSC Pool
To determine whether vascular targeting by downregulating the
expression of Notch ligands might directly block reconstitutionCell Stem Cell 6, 251–264, March 5, 2010 ª2010 Elsevier Inc. 257
Figure 5. E4ORF1+ ECs Prevent Attrition of KLS Cells through Notch Activation
(A) Quantitative RT-PCR for assessing Notch 1 and Notch 2 expression on day 21 cocultured hematopoietic cells.
(B) E4ORF1+ ECs were infected with adenovirus that overexpress a Notch decoy construct or an empty adenovirus. The Notch decoy significantly decreased the
ability of E4ORF1+ ECs to expand total hematopoietic cells and total TNR.Gfp+KLS cells.
(C–F) Notch1/Notch2/ lineage (N1N2/) BM cells (25,000 cells) were cocultured with E4ORF1+ ECs. BM cells were analyzed on weekly time points and
were demidepopulated each week.
(C) Total hematopoietic cell expansion was significantly decreased by day 21 in coculture with Notch1/Notch2/ versus WT BM cells.
(D) Total lineage hematopoietic cell expansion was significantly decreased by day 21 in coculture of Notch1/Notch2/ versus WT BM cells with
E4ORF1+ ECs.
(E) Total lineage+ hematopoietic cell expansion was significantly decreased by day 21 in coculture of Notch1/Notch2/ BM cells versus WT cells
E4ORF1+ ECs.
(F) Total CD34Flt3KLS cells (containing a large number of phenotypically marked HSCs) were significantly decreased by day 14 in cocultures of E4ORF1+ ECs
with Notch1/Notch2/ versus WT BM cells.
(G) Representative contour plots of phenotypic analysis of Notch1/Notch2/CD34Flt3KLS versus WT BM CD34Flt3KLS cells cocultured for 7, 14, and
21 days with E4ORF1+ ECs.
*p < 0.05, n = 6.
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image the regeneration of the repopulating TNR.Gfp+ LT-HSCs
during BM recovery model after 650 irradiation. Similar to WT
mice, the TNR.Gfp mice had full hemangiogenic recovery258 Cell Stem Cell 6, 251–264, March 5, 2010 ª2010 Elsevier Inc.(Figures 7A and 7B), whereas the TNR.Gfp mice treated with
the neutralizing mAbs to both VE-cadherin and VEGFR2 had
impaired restoration of the repopulating cells leading to the
demise of the treated animals (Figures 7A–7C). Analysis of the
Figure 6. Selective Vascular Targeting
Diminishes the Expression of Notch
Ligands on the Functional Patent SECs
(A) Full-lengthmontage Z-stacks of femurs of mice
under steady-state conditions and 650-irradiated
mice with and without vascular targeting that
received intravenous injection of low-dose VE-
cadherin Alexa 647 (red fluorescence) and Isolec-
tin GS-IB4 Alexa 488 (green fluorescence) to iden-
tify functional perfused vessels. Scale bars repre-
sent 500 mm in left andmiddle images and 50 mm in
right images.
(B) Mean fluorescence intensity of Jagged-1 and
Jagged-2 expression on the functional Isolec-
tin+VE-cadherin+CD45Ter119 BM endothelium
at steady-state and day 7 post 650-irradiation
with and without treatment with blocking mAbs
to VEGFR2 and VE-cadherin. Note the dramatic
decrease in mean fluorescence intensity of
the Jagged-1 and Jagged-2 expression on the
perfused patent Isolectin+VE-cadherin+ vessels
in the cohort of mice that were treated with the
neutralizing mAbs to VEGFR2 and VE-cadherin
(as compared to steady-state and day 7 650-irra-
diated no treatment cohorts).
(C) Quantification of functional patent SECs.
(D) Mean fluorescent intensity of Isolectin GS-IB4
gated on VE-cadherin+ BM endothelium. Error
bars represent SD, p % 0.05 as compared to no
treatment controls.
(E) Quantification of the mean fluorescence inten-
sity of the Notch ligands Jagged-1 and Jagged-2
expression. Error bars represent SD (*p % 0.05
as compared to no treatment controls).
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ating TNR.Gfp+ hematopoietic cells (Figures 6A and 7A),
whereas BM of control group manifested regeneration of the
TNR.Gfp+ hematopoietic cells (Figures 6A and 7A). The differ-
ence in mouse survival was significant between the two cohorts,
with the entire cohort of vascular-targeted TNR.Gfp mice dying
by day 14 after sublethal radiation (Figures 6B and 6C). Examina-
tion of organs of the irradiated mice treated with mAbs to
VE-cadherin and VEGFR2 did not show any apparent vascular
damage, suggesting that the death of these mAb-treated mice
was due to persistent pancytopenia.
Because the VEGFR2/VE-cadherin vascular-targeted cohort
began dying at day 10 post sublethal irradiation, we quantified
the total and TNR.Gfp+ hematopoietic cells per femur at day 7
postirradiation (Figures 7A and 7D), which showed a significant
decrease in total cell number and a complete abrogation in
the recovery of TNR.Gfp+ hematopoietic cells (Figure 7D). It
has been shown that TNR.Gfp+KLS population contains the
LT-HSCs, whereas the TNR.GfpKLS cells represents theCell Stem Cell 6, 251–2short-term repopulating HSCs (ST-HSCs)
(Wu et al., 2007). We found that approxi-
mately 7% of the regenerating hemato-
poietic cells at this time point were
TNR.Gfp+KLS cells (Figure 7E). Impor-
tantly, the vascular-targeted cohort failed
to show any evidence of TNR.Gfp+ KLScell expansion, but did contain TNR.GfpKLS cells at a lower
frequency as compared to the control group (Figure 7E). Upon
transplantation of TNR.Gfp+Sca-1+Lineage and TNR.Gfp
Sca-1+Lineage cells, we found that the TNR.Gfp+Sca-1+Line-
age subpopulation was highly enriched for LT-HSCs, whereas
the majority of the TNR.GfpSca-1+Lineage cells were unable
to sustain long-term hematopoietic engraftment (Figure 7F).
In 650-irradiated mice treated with mAbs to either VE-cad-
herin or VEGFR2, there was also a trend toward a decrease
in the number of TNR.Gfp+KLS population (Figure 7E), suggest-
ing that interfering with SEC function delays regeneration of
repopulating hematopoietic cells. Inhibition of VE-cadherin
was more effective than blocking the extracellular domain of
VEGFR2 in diminishing reconstitution of TNR.Gfp+KLS cells.
VE-cadherin inhibition through impairing the VEGFR2 intracel-
lular signaling enhances the anti-VEGFR2 mAb effect (Carmeliet
et al., 1999), which primarily inhibits the VEGFR2 extracellular-
mediated signaling. Hence, the combination of VE-cadherin
and VEGFR2 inhibition exerts a synergistic effect in impairing64, March 5, 2010 ª2010 Elsevier Inc. 259
Figure 7. Selective Disruption of SECs Angiocrine Function Inhibits Reconstitution of TNR.Gfp+ LT-HSCs
(A) Analysis of TNR.Gfp+ hematopoietic cells after 650 sublethally irradiation with or without administration of vascular targeting agents. There is a profound inhi-
bition of TNR.Gfp+ hematopoietic cell regeneration and the impaired remodeling of BM ECs manifesting as disrupted and dilated ECs (red stain) in the vascular-
targeted cohort (white arrowheads). TNR.Gfp+ cells reside in close proximity to the VE-cadherin+ SECs and are often cellularly positioned in between the bone
(osteoblastic cells) and vascular cells (white arrows and inserts in right panel of 650 rads treated alone mice). VE-cadherin+ ECs could be detected in the close
proximity of the GFP+ osteoblasts in the Col2.3GFPmice (insets), in which the expression of the GFP is restricted to the osteoblasts. Scale bars represent 50mm.
(B) Circulating blood counts in the control cohort versus the vascular-targeted cohort.
(C) Survival curve of both cohorts.
(D) Comparison of total hematopoietic cell numbers and populations between the control cohort and the vascular-targeted cohort at day 7 post sublethal irra-
diation.
(E) Total TNR.Gfp+ and TNR.Gfp KLS cells per femur. Targeting the SECs inhibits the regeneration of Notch-dependent phenotypically marked LT-HSCs.
(F) TNR.Gfp mice were sublethally irradiated with 650 Rads and at day 10 post sublethal irradiated BM was isolated and TNR.Gfp+Sca-1+Lineage (TNR.Gfp+)
and TNR.GfpSca-1+Lineage (TNR.Gfp) were sorted. 100 cells isolated from each of the sorted hematopoietic population were transplanted along with
300,000 NOD-SCID whole BM into irradiated NOD-SCID recipients (n = 5). TNR.Gfp+Sca-1+Lineage hematopoietic cells are highly enriched for LT-HSCs.
Note that the majority of the TNR.GfpSca-1+Lineage hematopoietic cells were unable to give rise to long-term engraftment. Only 1 out of 5 mice showed
long-term engraftment.
Error bars represent SD (*p < 0.05, n = 10).
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cells.
Because the majority of the TNR.Gfp+ cells comprise of
LT-HSCs at day 7 postsublethal irradiation (Figures 7D and
7E), the localization of the GFP+ regenerating hematopoietic
cells could identify the specific niches that support the expan-
sion of the repopulating hematopoietic cells. Thus, in vivo
tracking of TNR.Gfp+ cells serves to precisely locate regenerat-
ing LT-HSCs and ST-HSCs in the regenerating BM. We found
that TNR.Gfp+ hematopoietic cells were closely associated
with the VE-cadherin+ SECs (Figure 7A, 650 rads treated alone
mice). Notably, every regenerating TNR.Gfp+ hematopoietic
cells that were detected in close physical association with the
osteoblastic zone were also detected in direct apposition to
the SECs (Figure 7A, demarcated by thewhite arrows and inserts
in right panel of 650 rads treated alone mice) and (Figure S7).
These data suggest that direct cellular interaction of repopulat-
ing LT-HSCs with SECs is critical for the expansion of the
LT-HSCs after myelosuppression.
DISCUSSION
The self-renewal and differentiation of LT-HSCs is regulated by
interaction with niche cells. We have previously shown that
SECs is essential for reconstitution of hematopoiesis after mye-
loablation (Hooper et al., 2009). However, whether ECs have the
capacity to elaborate stem cell active angiocrine factors to
support the self-renewal of LT-HSCs and restore repopulating
HSC pool were not explored. Here, we have devised physiolog-
ically relevant angiogenic models to demonstrate that ECs,
through release of angiocrine factors, stimulate long-term
in vitro self-renewal of LT-HSCs and in vivo reconstitution of
the LT-HSC pool after myeloablation. Activation of Notch and
c-Kit reduces the attrition of TNR.Gfp+ LT-HSCs that undergo
coordinated self-renewal and differentiation in direct cellular
contact with ECs. We show that Notch1/Notch2/CD34
Flt-3KLS HSCs are functionally normal, but failed to expand
in coculture with ECs. Therefore, within the vascular niche,
release of sKitL (Heissig et al., 2002) and angiocrine expression
of Notch ligands by structurally intact perfused ECs establishes
an instructive niche for the restoration of LT-HCS pool. Collec-
tively, we demonstrate that E4ORF1+ ECs establish an ideal
vascular model not only to expand LT-HSCs for therapeutic
BM transplantation, but also to provide for an unlimited source
of ECs to identify as yet unrecognized factors that collaborate
with Notch and c-Kit signaling to balance LT-HSC expansion
and lineage-specific differentiation.
To interrogate the role of the vascular niche in vivo, we disrup-
ted the function of SECs with neutralizing mAbs to both VE-cad-
herin and extracellular domain of VEGFR2. Inhibiting both
VE-cadherin and VEGFR2 was essential to impair the prohema-
topoietic function of the SECs after myeloablation, as compared
to single antibody treatment with neutralizing mAb to either
VE-cadherin or VEGFR2, which resulted in only a partial delay
in hematopoietic recovery. The necessity to utilize both neutral-
izing mAbs was due to the inability of the VEGFR2 mAb to block
the intracellular tyrosine kinase activity of VEGFR2. Indeed,
because intrakine activity of VEGFR2 (Gerber et al., 2002) could
still impart proangiogenic signals to SECs, we employed mAb toVE-cadherin to significantly diminish VEGFR2 signaling (Carme-
liet et al., 1999). With this approach, we demonstrated that inhi-
bition of both VEGFR2 and VE-cadherin resulted in a profound
decrease in the instructive functionality of SECs leading to the
downregulation of Notch ligands, impaired reconstitution of
TNR.Gfp+ cells, and demise of the treated mice (Figure 6; Fig-
ure S6). These data suggest that during hematopoietic recovery
from myelodepletion, angiocrine expression of stem cell active
cytokines, such as Notch ligands, by SECs replenish the
TNR.Gfp+ LT-HSC population restoring hematopoiesis.
The present study indicates that ECs are not passive conduits
that support the delivery of oxygen and nutrients but also
through secretion of EC-derived angiocrine factors restore
LT-HSC population. We show that intact perfused SECs or
in vitro cultured ECs, through expression of Notch ligands,
prevent exhaustion of LT-HSCs, thereby replenishing the stem
cell mass within themyeloablated BM. The remarkable decrease
in the number of the TNR.Gfp+ HSCs in 650-irradiated mice
treated with vascular-targeting agents suggests that Notch
ligand+ SECs directly promote the expansion of the TNR.Gfp+
HSCs. We show that even in the 650-irradiated mice treated
with vascular targeting agents, a large number of structurally dis-
rupted vessels hadmaintained their functional perfusion patency
but had lost their capacity to express Notch ligands leading
to a significant decrease in the regeneration of TNR.Gfp+
LT-HSCs and TNR.Gfp+ ST-HSCs. However, we cannot rule
out the possibility that targeting SECs will not affect non-EC
stromal cells that could also express Notch ligands. Nonethe-
less, the finding that selective targeting of ECs interferes with
regeneration of TNR.Gfp+ LT-HSCs and TNR.Gfp+ ST-HSCs
indicates that SECs directly, independent of the non-EC stromal
cells, modulate the balance between expansion and lineage-
specific differentiation during hematopoietic recovery from
myeloablation.
Then how do ECs by elaboration of specific angiocrine factors
support both self-renewal and differentiation of the LT-HSCs and
progenitors? It is plausible that activation state of the ECs might
regulate the balance between expansion and lineage-specific
differentiation of the LT-HSCs. We show here that upregulation
of angiogenic factors favors the expression of Notch ligands
that shifts the balance toward expansion of LT-HSCs at the
expense of decelerating differentiation. By contrast, expression
of other cytokines, such as SDF-1 and FGF-4 (Avecilla et al.,
2004), which promote vascular-dependent thrombopoiesis in
TPO-deficient mice, favors differentiation of LT-HSCs. The
precise mechanism by which activation state of the ECs through
angiocrine release of cytokines balances LT-HSC expansion and
differentiation remains to be studied.
We have used human ECs to support expansion of murine
HSCs, suggesting that many stem cell-active cytokines, such
as Notch signaling pathway, can function in a cross-species
manner. However, in the case of sKitL, lack of cross-species
reactivity of this cytokine necessitates supplementation of the
medium with murine sKitL to facilitate murine HSC expansion.
Soluble KitL synergizes with E4ORF1+ ECs to expand HSCs by
two mechanisms, by increasing the survival of HSCs and also
by inducing the release of VEGF-A (Heissig et al., 2002), which
subsequently induces surface expression of Jagged-2 on the
ECs. Therefore, E4ORF1+ ECs constitute an efficient vascularCell Stem Cell 6, 251–264, March 5, 2010 ª2010 Elsevier Inc. 261
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LT-HSCs in serum-free conditions that could be used to screen
for instructive factors that support self-renewal of LT-HSCs.
Our study also sets forth the notion that angiocrine factors
released by ECs in vivo contribute to the replenishment of the
LT-HSC pool, thereby reconstituting hematopoiesis. It is plau-
sible that other as-of-yet unknown EC-derived angiocrine
factors might collaborate with sKitL to orchestrate self-renewal
of LT-HSCs, whereas Notch activation primarily prevent the
exhaustion of LT-HSCs. The establishment of serum- and cyto-
kine-free E4ORF1+ ECs provides for an ideal vascular niche
model to identify angiocrine factors that foster long-term self-
renewal and lineage-specific differentiation of HSCs. Factors
that promote vascular regeneration and modulate angiocrine
function of SECs offer novel therapeutic approaches to accel-
erate reconstitution of LT-HSCs after myeloablation as well as
to expand plenty of transplantable repopulating HSCs in vitro,
thereby ameliorating life-threatening pancytopenia associated
with chemo-irradiation. Furthermore, identification of angiocrine
factors elaborated by SECs may also shed light on the mecha-
nism by which myeloproliferative disorders evolve, thereby
opening new avenues of research to employ antiangiogenic
agents to target preleukemic syndromes.
EXPERIMENTAL PROCEDURES
Mice
All animal experiments were performed under the approval of Weill Medical
College of Cornell University’s Institutional Animal Care and Use Committee.
C57BL/6J (CD45.2) and TNR.Gfp mice were used at 8 weeks of age.
B6.SJL-Ptprca Pepcb/BoyJ mice were used as transplant recipients
(CD45.1) and were 10 weeks of age. NOD.CB17-Prkdcscid/J mice were used
at 10 weeks of age for transplantation of TNR.Gfp bone marrow (BM).
Col2.3Gfp mice were obtained from Dr. David Rowe at the University of
Connecticut.
Generation and Maintenance of E4ORF1+ ECs
The adenoviral E4ORF1 gene and/or Gfp derived from the serotype 5 adeno-
viruses were cloned into the lentivirus vector (Ramalingam et al., 1999; Sean-
del et al., 2008; Zhang et al., 2004, 2005). Lentiviruses were generated by
cotransfecting 15 mg of lentiviral vector, 3 mg of pENV/VSV-G, 5 mg of pRRE,
and 2.5 mg of pRSVREV in 293T cells (passage 8–10; subconfluent) by the
calcium precipitation method. Medium was changed 24 hr after transfection,
and supernatants were collected 40 hr and 64 hr after transfection. Superna-
tants were immediately sterile filtered via surfactant-free cellulose acetate
membranes, aliquoted, and stored at 80C.
Bone Marrow Endothelial Cell Isolation and Flow Cytometry
For quantification of the SECs (Figures 6A–6C), mice were injected by retro-
orbital sinus with 50 mg Isolectin GS IB4 conjugated to Alexa Fluor 488 (Alexa
488) and 10 mg of VE-cadherin (clone BV13, ImClone) conjugated to Alexa
Fluor 647 (Alexa 647). After 10 min, mice were sacrificed and whole BM from
femur was mechanically denuded of muscle and any connective tissue and
were then crushed in a sterile mortar. After 30 min of collagenase/dispase
digestion at 37C with agitation to release SEC from the BM microenviron-
ment, the single cells were the number of SEC were quantified and by costain-
ing with conjugated antibodies to CD45 (30F-11 BD PharMingen) and Ter119
(TER119 BD PharMingen). The number of functional SECs was quantified by
the number of Isolectin+VE-cadherin+CD45Ter119 cells per femur. The
intensity of the Isolectin expression was determined by calculating the mean
fluorescent intensity (MFI) with the FACSDiva software. Analysis of coexpres-
sion of Jagged-1 (R&D) or Jagged-2 (Biolegend) on the functional Isolectin+VE-
cadherin+CD45Ter119 SECs was determined by intracellular staining.
Isolectin+VE-cadherin+CD45Ter119 cells were fixed with 2% paraformalde-262 Cell Stem Cell 6, 251–264, March 5, 2010 ª2010 Elsevier Inc.hyde, permeabilized, and stained with either Jagged-1 or Jagged-2 directly
conjugated to PE. BM SECs were analyzed with a LSRII SORP (BD Biosci-
ences). All antibody staining was done at room temperature for 30 min.
Hematopoietic Cell Isolation, Hematopoietic Cell Culture, and Flow
Cytometry
Whole BM cells from C57BL/6J or TNR.Gfpmice were isolated and subjected
to Ficoll-Paque (GE Healthcare) gradient separation to enrich for mononuclear
cells. Cells were then enriched by three rounds of Lineage Cell Depletion (Mil-
tenyi Biotech) to ensure >95% purity. Cells underwent positive selection for
Sca-1 (Miltenyi Biotech) and were then stained with Sca-1 PE and cKit APC
and sorted with a Aria II SORP (BD Biosciences). One thousand KLS cells
were plated in a 12-well plate with or without E4ORF1+ ECs and both culture
conditions consisted of X-Vivo serum-free media (Lonza) supplemented with
10 ng/ml of soluble Kit Ligand (sKitL) (Biosource). Total hematopoietic cell
expansion, total Sca1+cKit+Lineage (KLS), and total CFU-C were analyzed
at weekly time points, where another Sca1+Lineage hematopoietic enrich-
ment was performed. Total cell number was determined with an Advia 120
(Bayer) automated hematological analyzer. Colony assays were performed
by placing 5000 cultured hematopoietic cells into methycellulose-based
media (Methocult GF M3434 from Stem Cell Technologies) with cytokines
and analyzed at day 7 for total colony number. Hematopoietic cells were
analyzed based on surface marker expression of c-Kit APC, Sca-1 PE-Cy7,
CD34 FITC, Flt-3 PE, and Lineage Alexa 350 expression. The combination
of the following antibodies defined the lineage markers: HM48-1 (anti-
CD48), MWReg30 (anti-CD41), 145-2C11 (antibody to CD3 (anti-CD3)),
53-7.3 (anti-CD5), GK1.5 (anti-CD4), 53-6.7 (anti-CD8), RB6-8C5 Ly-6G
(anti-Gr-1), M1/70 (anti-CD11b, Mac-1), Ter119 (antierythrocyte specific
antigen), and 6B2 (anti-B220). Other antibodies used included clones 2B8
(anti-CD117, anti-c-Kit), D7 (anti-Ly-6A/E, anti-Sca-1), RAM34 (anti-CD34),
and A2F10.1 (anti-CD135, Flt-3). All antibodies were purchased from PharMin-
gen or eBioscience. Hematopoietic cells were analyzed with a LSRII SORP (BD
Biosciences).
HSC Transplantation and LT-HSC Repopulation Studies
Freshly isolated CD45.2 Sca1+Lineage hematopoietic cells were cocultured
with or without E4ORF1+ ECs in X-Vivo serum-free media supplemented
with 10 ng/ml sKitL for 3 weeks. CD45.1 recipients were lethally irradiated
(950 Rads) and transplanted with test limiting dilution cell numbers, as indi-
cated, along with 200,000 CD45.1 standard competitive whole BM, and hema-
topoietic engraftment was monitored at 4, 8, 16, 24, and 48 weeks by FACS
analysis of peripheral blood for CD45.2/CD45.1 content (n = 6 for control;
n = 10 for all test cell dilutions). Secondary transplants were performed by
isolating whole BM from CD45.2/CD45.1 chimeric long-term multilineage en-
graftedmice. CD45.2 cells were sorted and transplanted into lethally irradiated
CD45.1 recipients and engraftment was monitored up to 48 weeks. Single-cell
transplants were performed in three independent experiments (n = 9, n = 19,
n = 19 for each culture condition). CD45.2 hematopoietic cells were cocultured
with or without E4ORF1+ ECs in X-Vivo serum-free media supplemented with
10 ng/ml sKitL for 3 weeks. Hematopoietic cells were Sca-1 enriched and
lineage depleted (Lineage, Lin) prior to use. 1, 5, 10, or 50 hematopoietic
cells were mouth pipetted and mixed with 200,000 CD45.1 whole BM. The
cell mixture was transplanted into CD45.1 lethally irradiated recipients. To
test the repopulating ability of TNR.Gfp+KLS cells, 1000 TNR.Gfp+KLS cells
were transplanted into irradiated NOD-SCID mice (3.5 Gy) with 300,000
NOD-SCID BM cells. Immunodeficient recipient mice were used because
the TNR.Gfp mice are on an outbred CD1 background. Transplanted mice
were bled every 4 weeks and peripheral blood analyzed to determine the level
of donor-derived chimerism.
In Vitro Inhibition of Notch Signaling
TNR.Gfp+ hematopoietic cells were cultured with E4ORF1+ ECs and sKitL for
3 weeks and then were treated for 3 days with a combination of monoclonal
human-specific neutralizing mAbs to VEGFR2 (1C11, 10 mg/ml, ImClone)
and VE-cadherin (BV9, 10 mg/ml, ImClone) to selectively disrupt the
E4ORF1+ ECs, 20 mM of a g-secretase inhibitor (Sigma) in 10% DMSO, or
10%DMSO to serve as a no-treatment control, or E4ORF1+ ECs were infected
with adenoviruses (50 MOI) that expressed a Notch decoy or AdNull for
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day. Percentage of TNR.Gfp+ hematopoietic cells was analyzed by flow
cytometry. The degree of differentiation of cultured cells was monitored by
staining of hematopoietic cells for expression of lineage cell surface markers
and was analyzed by flow cytometry.
Generation and Coculture of Notch1/Notch2/ BM
with E4ORF1+ ECs
Mice bearing both the floxed Notch1 and Notch2 genes were maintained and
bredwith transgenicmice bearing the interferon inducibleMx1-Cre gene at the
Fred Hutchinson Cancer Research Center. To generate Notch1/Notch2/
mice, the Mx1-Cre-Notch1fl/fl Notch2fl/fl 2- to 3-week-old mice were injected
with 25 mg/kg solution of Poly I/C (InvivoGen) over a 3 week period. They first
received a series of 5 i.p. injections every 2–3 days, followed by a 7 day break.
Subsequently, Lin hematopoietic cells were purified from the BM Notch1/
Notch2/mice. As control, Lin hematopoietic cells were also obtained from
the syngenic control wild-type mice. Genotype analyses confirmed knock-
down of Notch1 and Notch2 on the hematopoietic cells. 25,000 Notch1/
Notch2/ lineage-depleted BM cells were cocultured on E4ORF1+ ECs with
50 ng/mL of sKitL in 12-well plates. Both WT and the Notch1/Notch2/
hematopoietic cells were analyzed every 7 days by demidepopulating the
expanding hematopoietic populations and replating 25,000 Lin hematopoi-
etic cells on fresh E4ORF1+ ECs. Total cell hematopoietic cell, lineage-posi-
tive, lineage-negative, and CD34Flt-3KLS cell expansion was quantified
on a weekly basis.
Quantitative Real-Time PCR Analysis
RNA was freshly isolated from sKitL-stimulated cKit+LineageSca1+ (KLS)
HSCs, E4ORF1+ ECs, or day 21 cocultured hematopoietic cells with RNeasy
(Qaigen) andwas converted to cDNA via Superscript II (Invitrogen). Concentra-
tions of cDNA were measured with a Nanodrop. Quantitative real-time PCR
was done with a 7500 Fast Real-Time PCR System (Applied Biosystems) by
mixing equal amounts of cDNAs, iQ SYBR Green Supermix (BioRad), and
mouse VEGF-A164 (Fwd, AACAAAGCCAGAAAATCACTGTGA; and Rev,
CGGATCTTGGACAAACAAATGC) and b-actin (Fwd, CGTGCGTGACATCAA
AGAGAA; and Rev, GGCCATCTCCTGCTCGAA). Oligo sequences for qRT-
PCR of E4ORF1+ ECs are as follows: Dll1 (Fwd, CTACACGGGCAGGAACTG
CAG; and Rev, CGCCTTCTTGTTGGTGTTCTTG), Dll4 (Fwd, CGGGTCATC
TGCAGTGACAAC; and Rev, AGTTGAGATCTTGGTCACAAAACAG), Jagged1
(Fwd, GCTTGGATCTGTTGCTTGGTGAC; and Rev, ACTTTCCAAGTCTCT
GTTGTCCTG), and Jagged2 (Fwd, GCTATTTCGAGCTGCAGCTGAG; and
Rev, GCGGCAGGTAGAAGGAGTTG). Oligo sequences for qRT-PCR of day
21 cocultured cells: Notch 1 (Fwd, GGATCACATGGACCGATTGC; and Rev,
ATCCAAAAGCCGCACGATAT) and Notch 2 (Fwd, CCCCTTGCCCTCTATGT
ACCA; and Rev,GGTAGGTGGGAAAGCCACACT).
Selective Targeting of BM Vascular Niche In Vivo and HSC Function
TNR.Gfpmice were sublethally irradiated (650 Rads) andwere divided into two
cohorts (n = 20/cohort). One cohort was allowed to fully recover. The other
cohort was treated with monoclonal mouse-specific neutralizing antibodies
(mAb) to VEGFR2 (DC101, 800 mg/mouse, ImClone) and VE-cadherin (BV13,
50 mg/mouse, ImClone) to selectively target the vascular niche. Mice were
treated every other day for a total of 5 intraperitoneal injections. In a separate
experiment, the hematopoietic compartment (n = 5/cohort) was analyzed at
day 7. Total hematopoietic cell number per femur was determined by flushing
out femurs and counting using an hemacytometer. Total hematopoietic cells
derived from TNR.Gfp mice and total TNR.Gfp+ and TNR.GfpKLS cells
were determined by flow cytometry analysis and the percentage positive
was applied to the total cell count per femur in order to calculate the total
number per femur.
Immunostaining of Bone Sections and E4ORF1+ ECs
Freshly obtained bone specimens from TNR.Gfp that were sublethally irradi-
ated (650 Rads), with or without anti-VEGFR2/anti-VE-cadherin at indicated
time points, fixed overnight in 4Cwith 4% paraformaldehyde, and decalcified
for 2 hr at room temperature. The bones were then washed with 13 PBS for
30 min and either prepared for frozen sections or paraffin sections. For frozen
sections, bones were placed in 30% sucrose at 4C O/N and were thenembedded in Tissue-Tek Optimal Cutting Temperature (OCT). For paraffin
sections, bones were placed in 30% ethanol and then shipped to Histoserv,
Inc. Histoserv, Inc., cut 4–6 mmsections and performed hemotoxylin and eosin
staining. For immunofluorescence, sections/cells were postfixed for 15 min
with 4% paraformaldehyde and then were blocked with 10% normal donkey
serum/5% BSA/0.1% Triton X-100 for 1 hr. Bones were then incubated with
purified goat anti-mouse VE-cadherin antibody (R&D Systems, 1:50) O/N at
4C, followed by 1 hr incubation at room temperature with anti-goat Cy3 fluo-
rocrome (Jackson Immunoreasearch, 1:250). Primary ECs were grown to 70%
confluency and then were either stimulated or unstimulated with mouse VEGF-
A164 for 24 hr or 3 days. E4ORF1
+ ECs were post-fixed for 15 min in 4% para-
formaldehyde and blocked as described. E4ORF1+ ECs were then stained
with a rabbit anti-human/mouse Jagged-2 or Jagged-1 antibody (SantaCruz
Biotechnology) at 4C overnight, followed by 1 hr incubation at room temper-
ature with anti-rabbit Cy3 fluorocrome (Jackson Immunoreasearch, 1:250).
Sections/cells were stained for 20 min at room temperature with TOPRO-3
nuclear counterstain (Molecular Probes, 1:2000). Samples were mounted
with VectaShield (Vector Laboratories) and were viewed with appropriate
filters. For immunohistochemistry, paraffin slides were deparaffinized and
rehydrated, and heat-induced antigen was retrieved with Target Retrieval
Solution (DAKO, USA). Slides were treated with 0.1% H2O2 for 10 min. Slides
were blocked with 10% normal donkey serum/5% BSA/0.1% Triton X-100 for
1 hr. Slides were Avidin/Biotin blocked (Vector Laboratories). Slides were
stained with purified goat anti-mouse VE-cadherin antibody (R&D Systems,
1:100) O/N at 4C. After primary antibody incubation, sections were incubated
with appropriate secondary pAbs as follows: biotinylated donkey anti-rat
immunoglobulin G (IgG) or biotinylated donkey anti-goat IgG (Jackson Immu-
noresearch, 1:100). Staining was developed with horseradish peroxidase
(HRP)-conjugated streptavidin (Jackson Immunoresearch) followed by devel-
opment in AEC Ready-to-use (DAKO) and brief counterstaining in Mayer’s
hematoxylin (DAKO).
Peripheral Blood Analysis
Retro-orbital blood was collected on indicated days after sublethal irradiation
with capillary pipettes. Differential blood counts were obtained with an auto-
mated Advia 120 (Bayer). Error bars represent SD.
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